Blogs & News
Let’s Solve Your Breast Cancer Screening Journey With an FDA-approved Koning CT Breast Imaging Machine!
- by Shital
- on August 26, 2024
Many women face the negative experience of screening for breast cancer every year, and traditional methods of breast imaging can be uncomfortable and inefficient. However, with Koning 3D Breast Imaging, we’re proud to introduce a revolutionary approach to breast imaging that eliminates pain and inefficiencies in the screening process.
Koning CT Breast screening takes real isotropic 3D images of the breast in just 7 seconds, making it a fast and efficient screening process.
The 360-degree scanning angle allows for accurate detection of any concealed cancer cells that traditional 2D mammography might miss.
This technology’s accuracy eliminates the need for breast compression, ensuring that women can screen without pain and discomfort.
One of the greatest benefits of Koning Vera Breast CT is that it offers true isotropic 3D imaging, which enhances the accuracy and efficiency of breast imaging.
Traditional 2D mammography techniques can sometimes lead to overlapping structures that hide cancers and result in missed diagnoses. Koning Vera Breast CT technology eliminates this limitation, making it easier to detect cancer cells early on.
Moreover, the technology employed by Koning Vera Breast CT is safe and low in radiation effects, ensuring that women can get screened regularly without any worries.
The fast scan time and absence of compression make the screening process more convenient for women, leading to increased screening attendance, improved patient outcomes, and early treatment of breast cancer.
By making the breast screening process more accessible, comfortable, and precise, Koning 3D Breast Imaging is redefining breast health and setting a path towards the end of breast cancer as we know it.
With the accuracy and efficiency of this technology, more women can detect breast cancer early on. It leads to increased survival rates and improved quality of life.
Detected early improves breast cancer outcomes!
Koning Vera Breast CT device emerges as a game-changer, offering a multitude of benefits to both patients and healthcare providers. With a reduced scanning time of just 7 seconds, the Koning Vera Breast CT device opens up a new hope for early detection. It potentially saves lives by enabling prompt intervention.
The anxiety of waiting weeks for diagnostic results is a heavy burden that afflicts many individuals undergoing breast imaging and late in targeted treatments.
However, with the Koning Vera Breast CT, this burden is mitigated. Quick access to necessary treatments can be imposed. The speed and accuracy of this technology truly have the potential to transform the patient experience, setting a new standard for efficiency and precision in breast imaging.
Beyond its impact on patients, the Koning Vera Breast CT technology also supports healthcare providers in delivering superior care.
Radiologists benefit from a clearer and more direct visualisation of abnormalities, expediting the diagnostic process, and enhancing overall patient care.
This technological advancement equips medical professionals with the tools they need to achieve a deeper understanding of patients’ conditions and formulate targeted treatment plans.
Furthermore, the Koning Vera Breast CT can provide patient comfort in its design, offering a prone positioning on the Koning table that makes screenings more accessible and less intimidating breast compression during examinations.
This emphasis on patient well-being reflects a commitment to holistic care, ensuring that the entire breast imaging experience is supportive and respectful of the individual’s needs.
At Euronoxx Medical Group, we are thrilled to reflect our dedication to providing NHS and all UK GP healthcare professionals with innovative solutions that promote patient care.
Through our collaboration with clinics, NGOs, and local GP services – we aim to integrate the Koning Vera Breast CT FDA-approved scanning machines should be incorporated into breast health programs across the UK population.
Our anticipation of the likely impact of this groundbreaking technology is driven by a shared vision to advance breast healthcare and improve patients’ outcomes.
As we invite you to explore the efficiencies of the Koning breast CT FDA-approved machine, we extend an invitation to join us on the path to the end of breast cancer.
Together, we can propel the field of breast healthcare into a new era, free from the burden of breast cancer.
We encourage you to review the details below and consider the potential impact of this groundbreaking technology.
Should you have any questions or wish to discuss this journey with us, please do not hesitate to reach out.
In closing remarks, let us unite in our pursuit of a future where breast healthcare is marked by early detection, efficient treatment, and compassionate patient care.
With the advent of the Koning 3D breast CT, we stand at the forefront of a transformational journey that holds the promise of a world free from the burden of breast cancer.